#USA #Grand Rapids #Shoulder Innovations #Surgical Care #N-22 Humeral Head

FDA Clearance for N-22 Humeral Head

Shoulder Innovations, Inc., a leading medical technology company, has recently achieved a significant milestone in their journey towards enhancing shoulder surgical care. On September 10, 2026, the company proudly announced that it had received FDA 510(k) clearance for its N-22 Humeral Head. This new titanium implant is specifically designed for patients with metal hypersensitivity, a condition that affects approximately 10% to 15% of the population.

A Game-Changer for Metal-Hypersensitive Patients

Metal hypersensitivity can result in chronic pain and various allergic reactions, making it a challenge for affected individuals to undergo procedures involving traditional metal implants. Recognizing this pressing need, the N-22 Humeral Head has been engineered to be compatible with anatomic total shoulder arthroplasty procedures. It represents a welcomed alternative for patients who often experience persistent discomfort from conventional materials.

With this latest innovation, Shoulder Innovations continues to expand its offerings, complementing the already established N-22 Glenosphere implant that was cleared back in January 2026. Together, these products form an advanced solution for patients requiring shoulder implants, addressing both anatomic and reverse total shoulder arthroplasty procedures.

Insights from Leadership

Rob Ball, CEO of Shoulder Innovations, emphasized the importance of this new addition. "The N-22 Humeral Head augments our line of technologies for patients with metal hypersensitivity," he stated. "Now, surgeons have a metal-sensitive option across both shoulder arthroplasty configurations." This strategic move not only bolsters their product line but also reinforces the company's commitment to improving surgeon and patient relationships, especially in the face of ongoing expansion across the U.S. market.

Innovations Beyond Implants

Shoulder Innovations has positioned itself as a forward-thinking entity in the medical technology sphere, focusing exclusively on shoulder care. Their ecosystem integrates advanced implant systems and efficient procedural tools aimed at improving outcomes for both surgeons and patients. By innovating in areas such as preoperative planning and procedural efficiency, the company aims to deliver predictable results and simplify surgeries across various care settings.

In addition to the N-22 Humeral Head, the company continues to invest in enabling technologies and specialized support systems. This comprehensive approach is designed to tackle the long-standing challenges faced by medical professionals in the shoulder surgical market.

The Road Ahead

With the launch of the N-22 Humeral Head, Shoulder Innovations is set to make a lasting impact on the landscape of shoulder surgery for those affected by metal hypersensitivity. By providing solutions that meet the unique needs of these patients, the company not only enhances surgical options but also contributes to an overall increase in patient satisfaction and post-operative success rates.

As they move forward, the company looks to cultivate partnerships with surgeons and healthcare facilities, fostering a collaborative environment that prioritizes patient care and innovative surgical practices. In a market that is ever-evolving, Shoulder Innovations stands at the forefront, ready to shape the future of shoulder surgical care while solidifying their position as a leader in the industry.